Tiny molecules could stop glaucoma before it blinds

Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma. Their research shows these compounds are lower in glaucoma patients, suggesting they may serve as early warning markers. Even better, they might help protect retinal cells from damage, potentially slowing or stopping vision loss. The discovery could revolutionize how the disease is detected and treated.